Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis

Biochemical Pharmacology

Volumn 64, Issue 12, 2002, Pages 1677-1687

  Liu, Wei Jun ^a   Jiang, Jian Fei ^a   Xiao, Dong ^a   Ding, Jian ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Protein dephosphorylation; Salvicine; Telomerase

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; GYRASE INHIBITOR; MESSENGER RNA; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN; SALVACINE; TELOMERASE; TELOMERASE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TIME;

APOPTOSIS; CASPASES; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA; NAPHTHOQUINONES; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; TELOMERASE;

EID: 0037114491     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01424-7     Document Type: Article

References (48)

1. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
2. Kyo S., Kanaya T., Ishikawa H., Ueno H., Inoue M. Telomerase activity in gynecological tumors. Clin. Cancer Res. 2:1996;2023-2038.
3. Shay J.W., Wright W.E. Telomeres and telomerase: implications for cancer and aging. Radiat. Res. 155:2001;188-193.
4. Mandal M., Kumar R. Bcl-2 modulates telomerase activity. J. Biol. Chem. 272:1997;14183-14187.
5. Fu W., Begley J.G., Killen M.W., Mattson M.P. Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274:1999;7264-7271.
6. Koga S., Kondo Y., Komata T., Kondo S. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA. Gene Ther. 8:2001;654-658.
7. Herbert B., Pitts A.E., Baker S.I., Hamilton S.E., Wright W.E., Shay J.W., Corey D.R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14276-14281.
8. Kondo S., Tanaka Y., Kondo Y., Hitomi M., Barnett G.H., Ishizaka Y., Liu J., Haqqi T., Nishiyama A., Villeponteau B., Cowell J.K., Barna B.P. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J. 12:1998;801-811.
9. Jiang J.F., Liu W.J., Ding J. Regulation of telomerase activity in camptothecin-induced apoptosis of human leukemia HL-60 cells. Acta Pharmacol. Sin. 21:2000;759-764.
10. Zhang Z., Liong E.C., Lau T.Y., Leung K.M., Fung P.C., Tipoe G.L. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Int. J. Oncol. 16:2000;887-892.
11. Sato N., Mizumoto K., Kusumoto M., Nishio S., Maehara N., Urashima T., Ogawa T., Tanaka M. Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br. J. Cancer. 82:2000;1819-1826.
12. Zhang J.X., Zhang Z.K., Sheng H.P., Tsao S.W., Loh T.T. Telomerase activity is not related to apoptosis in leukemic cell lines. Life Sci. 66:2000;1713-1723.
13. Zhang J.S., Ding J., Tang Q.M., Li M., Zhao M., Lu L.J., Chen L.J., Yuan S.T. Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs. Bioorg. Med. Chem. Lett. 9:1999;2731-2736.
14. Qing C., Zhang J.S., Ding J. In vitro cytotoxicity of salvicine, a novel diterpenoid quinone. Acta Pharmacol. Sin. 20:1999;297-302.
15. Meng L.H., Zhang J.S., Ding J. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem. Pharmacol. 62:2001;733-741.
16. Meng L.H., He X.X., Zhang J.S., Ding J. DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae. Acta Pharmacol. Sin. 22:2001;741-746.
17. Qing C., Jiang C., Zhang J.S., Ding J. Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound. Anticancer Drugs. 12:2001;51-56.
18. Meng L., Ding J. Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells. FEBS Lett. 501:2001;59-64.
19. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
20. Kim N.W., Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:1997;2595-2597.
21. Feng J., Funk W.D., Wang S.-S., Weinrich S.L., Avilion A.A., Chiu C.-P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science. 269:1995;1236-1241.
22. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., Weinberg R.A. hEST2 the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
23. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., Arruda I., Robinson M.O. A mammalian telomerase-associated protein. Science. 275:1997;973-977.
24. Nakayama J., Saito M., Nakamura H., Matsuura A., Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 88:1997;875-884.
25. Li H., Zhao L.L., Funder J.W., Liu J.P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272:1997;16729-16732.
26. Santoro M.F., Annand R.R., Robertson M.M., Peng Y.W., Brady M.J., Mankovich J.A., Hackett M.C., Ghayur T., Walter G., Wong W.W., Giegel D.A. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J. Biol. Chem. 273:1998;13119-13128.
27. Liu J.P. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13:1999;2091-2104.
28. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
29. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
30. Günes C., Lichtsteiner S., Vasserot A.P., Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60:2000;2116-2121.
31. Xu D., Gruber A., Bjorkholm M., Peterson C., Pisa P. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br. J. Cancer. 80:1999;1156-1161.
32. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5147-5152.
33. Lin Z., Lim S., Viani M.A., Sapp M., Lim M.S. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am. J. Pathol. 159:2001;711-719.
34. Reichman T.W., Albanell J., Wang X., Moore M.A., Studzinski G.P. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J. Cell Biochem. 67:1997;13-23.
35. Avilion A.A., Piatyszek M.A., Gupta J., Shay J.W., Bacchetti S., Greider C.W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:1996;645-650.
36. Kharbanda S., Kumar V., Dhar S., Pandey P., Chen C., Majumder P., Yuan Z.M., Whang Y., Strauss W., Pandita T.K., Weaver D., Kufe D. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr. Biol. 10:2000;568-575.
37. Millward T.A., Zolnierowicz S., Hemmings B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:1999;186-191.
38. Mumby M.C., Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73:1993;673-699.
39. Neuzil J., Weber T., Schröder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Nègre-Salvayre A., Stícha M., Coffey R.J., Weber C. Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 15:2001;403-415.
40. Parameswaran N., Nambi P., Hall C.S., Brooks D.P., Spielman W.S. Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur. J. Pharmacol. 388:2000;133-138.
41. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:2001;417-439.
42. Kowluru A., Metz S.A. Ceramide-activated protein phosphatase-2A activity in insulin-secreting cells. FEBS Lett. 418:1997;179-182.
43. Leoni L.M., Shih H.C., Deng L., Tuey C., Walter G., Carson D.A., Cottam H.B. Modulation of ceramide-activated protein phosphatase 2A activity by low molecular weight aromatic compounds. Biochem. Pharmacol. 55:1998;1105-1111.
44. Ruvolo P.P., Deng X., Ito T., Carr B.K., May W.S. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274:1999;20296-20300.
45. Hannun Y.A., Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:2000;73-80.
46. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., Sokoloski J.A., Hsiao R., Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6091-6095.
47. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature. 392:1998;569-574.
48. Ishibashi T., Lippard S.J. Telomere loss in cells treated with cisplatin. Proc. Natl. Acad Sci. U.S.A. 95:1998;4219-4223.